| UniProt ID | ZKSC1_HUMAN | |
|---|---|---|
| UniProt AC | P17029 | |
| Protein Name | Zinc finger protein with KRAB and SCAN domains 1 | |
| Gene Name | ZKSCAN1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 563 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | May be involved in transcriptional regulation.. | |
| Protein Sequence | MMTAESREATGLSPQAAQEKDGIVIVKVEEEDEEDHMWGQDSTLQDTPPPDPEIFRQRFRRFCYQNTFGPREALSRLKELCHQWLRPEINTKEQILELLVLEQFLSILPKELQVWLQEYRPDSGEEAVTLLEDLELDLSGQQVPGQVHGPEMLARGMVPLDPVQESSSFDLHHEATQSHFKHSSRKPRLLQSRALPAAHIPAPPHEGSPRDQAMASALFTADSQAMVKIEDMAVSLILEEWGCQNLARRNLSRDNRQENYGSAFPQGGENRNENEESTSKAETSEDSASRGETTGRSQKEFGEKRDQEGKTGERQQKNPEEKTRKEKRDSGPAIGKDKKTITGERGPREKGKGLGRSFSLSSNFTTPEEVPTGTKSHRCDECGKCFTRSSSLIRHKIIHTGEKPYECSECGKAFSLNSNLVLHQRIHTGEKPHECNECGKAFSHSSNLILHQRIHSGEKPYECNECGKAFSQSSDLTKHQRIHTGEKPYECSECGKAFNRNSYLILHRRIHTREKPYKCTKCGKAFTRSSTLTLHHRIHARERASEYSPASLDAFGAFLKSCV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 6 | Phosphorylation | --MMTAESREATGLS --CCCHHHHHHHCCC | 32.72 | - | |
| 10 | Phosphorylation | TAESREATGLSPQAA CHHHHHHHCCCHHHH | 33.62 | 30266825 | |
| 13 | Phosphorylation | SREATGLSPQAAQEK HHHHHCCCHHHHHHC | 19.13 | 29255136 | |
| 20 | Ubiquitination | SPQAAQEKDGIVIVK CHHHHHHCCCEEEEE | 49.53 | - | |
| 27 | Sumoylation | KDGIVIVKVEEEDEE CCCEEEEECCCCCCC | 32.57 | 28112733 | |
| 42 | Phosphorylation | DHMWGQDSTLQDTPP CCCCCCCCCCCCCCC | 24.11 | 27732954 | |
| 43 | Phosphorylation | HMWGQDSTLQDTPPP CCCCCCCCCCCCCCC | 36.41 | 27732954 | |
| 47 | Phosphorylation | QDSTLQDTPPPDPEI CCCCCCCCCCCCHHH | 25.41 | 30576142 | |
| 166 | Phosphorylation | PLDPVQESSSFDLHH ECCCCCCCCCCCCCC | 17.75 | 28348404 | |
| 167 | Phosphorylation | LDPVQESSSFDLHHE CCCCCCCCCCCCCCH | 33.98 | 28348404 | |
| 168 | Phosphorylation | DPVQESSSFDLHHEA CCCCCCCCCCCCCHH | 31.87 | 28348404 | |
| 178 | Phosphorylation | LHHEATQSHFKHSSR CCCHHHHHHHCCCCC | 26.91 | 28555341 | |
| 181 | Ubiquitination | EATQSHFKHSSRKPR HHHHHHHCCCCCCCC | 36.83 | - | |
| 181 | Sumoylation | EATQSHFKHSSRKPR HHHHHHHCCCCCCCC | 36.83 | 28112733 | |
| 184 | Phosphorylation | QSHFKHSSRKPRLLQ HHHHCCCCCCCCHHH | 44.00 | - | |
| 208 | Phosphorylation | PAPPHEGSPRDQAMA CCCCCCCCHHHHHHH | 17.49 | 29255136 | |
| 216 | Phosphorylation | PRDQAMASALFTADS HHHHHHHHHHHCCCC | 16.66 | 24247654 | |
| 223 | Phosphorylation | SALFTADSQAMVKIE HHHHCCCCCCCHHHH | 19.85 | - | |
| 228 | Sumoylation | ADSQAMVKIEDMAVS CCCCCCHHHHHHHHH | 27.56 | 28112733 | |
| 252 | Phosphorylation | NLARRNLSRDNRQEN HHHHCCCCCCCCHHH | 40.93 | 27251275 | |
| 262 | Phosphorylation | NRQENYGSAFPQGGE CCHHHCCCCCCCCCC | 19.17 | 27251275 | |
| 279 | Phosphorylation | NENEESTSKAETSED CCCHHHCCCCCCCHH | 38.86 | 28555341 | |
| 280 | Sumoylation | ENEESTSKAETSEDS CCHHHCCCCCCCHHH | 50.78 | 28112733 | |
| 280 | Ubiquitination | ENEESTSKAETSEDS CCHHHCCCCCCCHHH | 50.78 | 21906983 | |
| 280 | Sumoylation | ENEESTSKAETSEDS CCHHHCCCCCCCHHH | 50.78 | - | |
| 283 | Phosphorylation | ESTSKAETSEDSASR HHCCCCCCCHHHHHC | 42.13 | 25850435 | |
| 284 | Phosphorylation | STSKAETSEDSASRG HCCCCCCCHHHHHCC | 30.80 | 25850435 | |
| 287 | Phosphorylation | KAETSEDSASRGETT CCCCCHHHHHCCCCC | 24.88 | 29255136 | |
| 289 | Phosphorylation | ETSEDSASRGETTGR CCCHHHHHCCCCCCC | 44.78 | 29255136 | |
| 293 | Phosphorylation | DSASRGETTGRSQKE HHHHCCCCCCCCHHH | 37.06 | 29255136 | |
| 294 | Phosphorylation | SASRGETTGRSQKEF HHHCCCCCCCCHHHH | 26.71 | 29255136 | |
| 299 | Sumoylation | ETTGRSQKEFGEKRD CCCCCCHHHHHHHHC | 57.15 | 28112733 | |
| 304 | Sumoylation | SQKEFGEKRDQEGKT CHHHHHHHHCCCCCC | 62.75 | 28112733 | |
| 310 | Acetylation | EKRDQEGKTGERQQK HHHCCCCCCCHHHHC | 53.24 | 18586575 | |
| 330 | Phosphorylation | TRKEKRDSGPAIGKD HHHHHHCCCCCCCCC | 51.19 | 30576142 | |
| 336 | Acetylation | DSGPAIGKDKKTITG CCCCCCCCCCCCCCC | 61.33 | 25953088 | |
| 339 | Sumoylation | PAIGKDKKTITGERG CCCCCCCCCCCCCCC | 56.12 | 28112733 | |
| 339 | Sumoylation | PAIGKDKKTITGERG CCCCCCCCCCCCCCC | 56.12 | - | |
| 357 | Phosphorylation | KGKGLGRSFSLSSNF CCCCCCCCEECCCCC | 19.86 | 25159151 | |
| 359 | Phosphorylation | KGLGRSFSLSSNFTT CCCCCCEECCCCCCC | 28.70 | 25159151 | |
| 361 | Phosphorylation | LGRSFSLSSNFTTPE CCCCEECCCCCCCCC | 23.26 | 28348404 | |
| 362 | Phosphorylation | GRSFSLSSNFTTPEE CCCEECCCCCCCCCC | 41.05 | 28348404 | |
| 365 | Phosphorylation | FSLSSNFTTPEEVPT EECCCCCCCCCCCCC | 45.77 | 30108239 | |
| 366 | Phosphorylation | SLSSNFTTPEEVPTG ECCCCCCCCCCCCCC | 25.27 | 25159151 | |
| 372 | Phosphorylation | TTPEEVPTGTKSHRC CCCCCCCCCCCCCCC | 63.76 | 22199227 | |
| 374 | Phosphorylation | PEEVPTGTKSHRCDE CCCCCCCCCCCCCCC | 31.67 | 26074081 | |
| 375 | Ubiquitination | EEVPTGTKSHRCDEC CCCCCCCCCCCCCCC | 45.68 | - | |
| 375 | Sumoylation | EEVPTGTKSHRCDEC CCCCCCCCCCCCCCC | 45.68 | 28112733 | |
| 384 | Ubiquitination | HRCDECGKCFTRSSS CCCCCCCCCCCCCHH | 37.52 | - | |
| 390 | Phosphorylation | GKCFTRSSSLIRHKI CCCCCCCHHHHCCEE | 26.35 | 24719451 | |
| 391 | Phosphorylation | KCFTRSSSLIRHKII CCCCCCHHHHCCEEE | 29.12 | 24719451 | |
| 396 | Ubiquitination | SSSLIRHKIIHTGEK CHHHHCCEEEECCCC | 33.24 | - | |
| 400 | Phosphorylation | IRHKIIHTGEKPYEC HCCEEEECCCCCEEC | 36.31 | 29496963 | |
| 403 | Ubiquitination | KIIHTGEKPYECSEC EEEECCCCCEECCCC | 55.00 | - | |
| 405 | Phosphorylation | IHTGEKPYECSECGK EECCCCCEECCCCCC | 40.41 | - | |
| 408 | Phosphorylation | GEKPYECSECGKAFS CCCCEECCCCCCEEE | 24.79 | 27251275 | |
| 412 | Sumoylation | YECSECGKAFSLNSN EECCCCCCEEECCCC | 58.90 | 28112733 | |
| 412 | Sumoylation | YECSECGKAFSLNSN EECCCCCCEEECCCC | 58.90 | - | |
| 415 | Phosphorylation | SECGKAFSLNSNLVL CCCCCEEECCCCEEE | 31.34 | 28555341 | |
| 418 | Phosphorylation | GKAFSLNSNLVLHQR CCEEECCCCEEEEEE | 36.51 | 28555341 | |
| 428 | Phosphorylation | VLHQRIHTGEKPHEC EEEEEECCCCCCCCC | 44.67 | 27282143 | |
| 440 | Sumoylation | HECNECGKAFSHSSN CCCCCCHHCCCCCCC | 58.90 | 28112733 | |
| 443 | Phosphorylation | NECGKAFSHSSNLIL CCCHHCCCCCCCEEE | 27.59 | 23312004 | |
| 445 | Phosphorylation | CGKAFSHSSNLILHQ CHHCCCCCCCEEEEE | 21.52 | 23312004 | |
| 446 | Phosphorylation | GKAFSHSSNLILHQR HHCCCCCCCEEEEEE | 30.17 | 23312004 | |
| 456 | Phosphorylation | ILHQRIHSGEKPYEC EEEEECCCCCCCEEC | 46.40 | 26657352 | |
| 459 | Ubiquitination | QRIHSGEKPYECNEC EECCCCCCCEECCCC | 57.32 | - | |
| 461 | Phosphorylation | IHSGEKPYECNECGK CCCCCCCEECCCCHH | 44.15 | 23312004 | |
| 468 | Ubiquitination | YECNECGKAFSQSSD EECCCCHHHHHCCCC | 58.90 | - | |
| 471 | Phosphorylation | NECGKAFSQSSDLTK CCCHHHHHCCCCCCC | 33.73 | 17525332 | |
| 473 | Phosphorylation | CGKAFSQSSDLTKHQ CHHHHHCCCCCCCCC | 25.31 | 23312004 | |
| 478 | Sumoylation | SQSSDLTKHQRIHTG HCCCCCCCCCCCCCC | 45.07 | 28112733 | |
| 478 | Ubiquitination | SQSSDLTKHQRIHTG HCCCCCCCCCCCCCC | 45.07 | - | |
| 478 | Sumoylation | SQSSDLTKHQRIHTG HCCCCCCCCCCCCCC | 45.07 | - | |
| 484 | Phosphorylation | TKHQRIHTGEKPYEC CCCCCCCCCCCCCCC | 44.67 | 29496963 | |
| 489 | Phosphorylation | IHTGEKPYECSECGK CCCCCCCCCCCHHHH | 40.41 | - | |
| 492 | Phosphorylation | GEKPYECSECGKAFN CCCCCCCCHHHHCCC | 24.79 | 27251275 | |
| 496 | Sumoylation | YECSECGKAFNRNSY CCCCHHHHCCCCCCE | 62.56 | - | |
| 496 | Ubiquitination | YECSECGKAFNRNSY CCCCHHHHCCCCCCE | 62.56 | - | |
| 496 | Sumoylation | YECSECGKAFNRNSY CCCCHHHHCCCCCCE | 62.56 | - | |
| 502 | Phosphorylation | GKAFNRNSYLILHRR HHCCCCCCEEEEECC | 20.34 | 30108239 | |
| 503 | Phosphorylation | KAFNRNSYLILHRRI HCCCCCCEEEEECCE | 11.00 | 30108239 | |
| 527 | Phosphorylation | TKCGKAFTRSSTLTL CCCCCEEECCCCEEH | 34.20 | 28555341 | |
| 529 | Phosphorylation | CGKAFTRSSTLTLHH CCCEEECCCCEEHHH | 25.31 | 23312004 | |
| 530 | Phosphorylation | GKAFTRSSTLTLHHR CCEEECCCCEEHHHH | 24.93 | 28555341 | |
| 531 | Phosphorylation | KAFTRSSTLTLHHRI CEEECCCCEEHHHHH | 25.63 | 23312004 | |
| 533 | Phosphorylation | FTRSSTLTLHHRIHA EECCCCEEHHHHHHH | 24.92 | 23312004 | |
| 545 | Phosphorylation | IHARERASEYSPASL HHHHHHHHHCCCHHH | 43.20 | 23403867 | |
| 547 | Phosphorylation | ARERASEYSPASLDA HHHHHHHCCCHHHHH | 19.91 | 23403867 | |
| 548 | Phosphorylation | RERASEYSPASLDAF HHHHHHCCCHHHHHH | 15.22 | 28176443 | |
| 551 | Phosphorylation | ASEYSPASLDAFGAF HHHCCCHHHHHHHHH | 30.11 | 28176443 | |
| 560 | Ubiquitination | DAFGAFLKSCV---- HHHHHHHHHCC---- | 35.04 | - | |
| 560 | Sumoylation | DAFGAFLKSCV---- HHHHHHHHHCC---- | 35.04 | 28112733 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZKSC1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZKSC1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZKSC1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| ZSC32_HUMAN | ZSCAN32 | physical | 25416956 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13 AND SER-208, AND MASSSPECTROMETRY. | |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-471, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND MASSSPECTROMETRY. | |